FierceBiotech

Enbrel® (etanercept) Significantly Improved Scalp Involvement in Patients with Moderate to Severe Plaque Psoriasis | Fierce Biotech

THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., Feb. 4, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) and Pfizer Inc. (NYSE: PFE) today announced results from a new trial that demonstrated Enbrel® ...
FierceBiotech

Enbrel® (etanercept) Patent Issued

THOUSAND OAKS, Calif., Nov. 22, 2011 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today issued the following statement: Amgen today announced the issuance of U.S. Patent No. 8,063,182 related to Enbrel ® ...
EurekAlert!

ENBREL is first therapy approved for psoriatic arthritis

SEATTLE, WA – Immunex Corporation (Nasdaq: IMNX) and Wyeth-Ayerst Laboratories, a division of American Home Products (NYSE: AHP) announced today that the U.S. Food and Drug Administration (FDA) has ...
EurekAlert!

New Phase 2 study shows ankylosing spondylitis patients respond to ENBREL® (etanercept)

SAN FRANCISCO, November 11, 2001– Data from a Phase 2 clinical study of ENBREL® (etanercept) in ankylosing spondylitis will be presented this week at the 65th Annual Scientific Meeting of the American ...
Healio

Etanercept improved HbA1c, insulin production in youth with type 1 diabetes

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Youth with newly diagnosed type 1 ...
Business Wire

FDA Approves ETICOVO™ (etanercept-ykro), Samsung Bioepis' Second Anti-TNF Medicine in the United States

INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced that the US Food and Drug Administration (FDA) has approved ETICOVO™ (etanercept-ykro), a biosimilar referencing ENBREL ® ...
Forbes

Blockbuster Biologic Enbrel Will Continue As A Monopoly For Another 8 Years

On Monday, May 17 th, the U.S. Supreme Court decided not to take up Sandoz’s petition for the Court to review previous lower court decisions on the launch of its biosimilar product. This included a ...
Healio

Re-treatment with etanercept effective in juvenile idiopathic arthritis

Please provide your email address to receive an email when new articles are posted on . Approximately 70% of patients with juvenile idiopathic arthritis who are re-treated with etanercept achieve ...
FiercePharma

Enbrel® (etanercept) Significantly Improved Scalp Involvement in Patients with Moderate to Severe Plaque Psoriasis

THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., Feb. 4, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) and Pfizer Inc. (NYSE: PFE) today announced results from a new trial that demonstrated Enbrel® ...